Tell us about you

Work Email required

Organization required

First Name required

Last Name required

Job Title required

Phone required (###) ###-####, or int ######...

City required

State/Province required

Tell us about your organization

error messages will go here...

Looks like we’re already familiar with you!

Please press next to continue with the survey.

Looks like we’re already familiar with you!

According to your account type you are not eligible to take surveys at this time. If this is a mistake, please contact KLAS.

If you are trying to access KLAS research data and reports, an email has been sent to   with a link to login.

If the email doesn't appear in your inbox, ask your IT department to add KLASresearch.com to your company spam filter's "whitelist", and check your email's spam folder.

Membership Commitment

In exchange for giving their feedback, healthcare providers can create an account to get access to industry reports, user commentary, and real-time ratings.

By submitting your account request, you are engaged in patient care as either an employee (or contractor) of your provider organization and that you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically. To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

Thank You! Your information was submitted successfully!

Next Steps - An email has been sent to . Please follow its instructions to verify your email, and login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank You! Your information was submitted successfully!

Next Steps - A KLAS representative will contact you to discuss working with KLAS, typically within 24 to 48 hours.

If you have any further questions please contact info@klasresearch.com or 1-800-920-4109.

Surprise! Looks like we already have an account for you.

An email has been sent to blah@blah.com with a link to login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

The Irony of the 340B Program - Cover

The Irony of the 340B Program

Since 1992, qualifying organizations have been able to participate in the discount drug program known as 340B. Through this program, covered entities are able to receive significant discounts and potentially save millions on pharmaceutical reorders to benefit their indigent populations. With the long-standing program has come an increase in HRSA government audits to regulate participants and assure that providers meet intended guidelines. 

These audits have influenced an increase in the number of vendors that offer, among other services, the help and expertise to prepare for and sufficiently prove compliance during a potential audit. Ironically, providers who qualify for the 340B cost savings are now having to spend money to prepare for audits from the very organization that authorized their participation in the program in the first place. After all, you can’t best use an umbrella unless there is some rain to go with it!

As discussed in the 2014 KLAS report 340B Management Systems: Relieving the Audit Pressure, 340B management systems certainly provide more than just audit preparation. These solutions help split drug purchases to give providers the opportunity to maximize discounts. They also provide analytics and internal reporting tools and help cross-reference NDC codes to billing codes. Although these additional tools are helpful, the audit-preparation features certainly seem to be driving the market energy right now.

Providers who align with the intended purposes of the program will benefit from the additional functionalities offered from today’s 340B vendors. As healthcare providers continue to seek cost-saving measures, 340B will likely continue to be a highly impactful program that can benefit many patients. Will ongoing audits uncover expectations of more regulation? In the future KLAS will look to speak with more providers who have gone through a HRSA audit so they can share their experiences with others. Please share your thoughts below. 

Klas blogs

Latest tweets